Treatment of Lipid Metabolism Disturbances in Autoimmune Diseases

N. Ronda, P. L. Meroni

Research output: Chapter in Book/Report/Conference proceedingChapter


Autoimmune diseases are associated with increased cardiovascular (CV) risk, not only in consequence of specific disease-driven autoimmune processes targeting the vessels and the heart, but also because of accelerated atherosclerosis. The latter itself is a complex multifactorial process influenced by both classical and autoimmune disease–associated risk factors. Notwithstanding the increasing awareness of the problem, cardiovascular disease prevention and management in autoimmune disorders are still insufficient. The complex and peculiar lipid metabolism disturbances demonstrated in autoimmune patients raise uncertainty on the use of the classical lipid indexes for CV risk calculation and on the usefulness of lipid-lowering drugs. Treatment of lipid disturbances in autoimmune diseases at present is based on: control of disease activity, which should be obtained through a careful choice of the less atherogenic drugs as possible; modulation of serum lipoprotein levels with healthy lifestyle/diet, nutraceuticals, and drugs; modulation of lipoprotein functions with healthy lifestyle/diet, nutraceuticals, and drugs.

Original languageEnglish
Title of host publicationHandbook of Systemic Autoimmune Diseases
PublisherElsevier Ltd
Number of pages14
Publication statusPublished - Jan 1 2017

Publication series

NameHandbook of Systemic Autoimmune Diseases
ISSN (Print)1571-5078


  • Atherosclerosis
  • Autoimmune
  • Dyslipidemia
  • Lipid metabolism
  • Lipoprotein
  • Nutraceuticals

ASJC Scopus subject areas

  • Immunology and Allergy
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Treatment of Lipid Metabolism Disturbances in Autoimmune Diseases'. Together they form a unique fingerprint.

Cite this